Nano-X Imaging Ltd.
HealthcareNASDAQ:NNOX · NASDAQ Global Market
+$0.05 today
Vol 0.66M · Avg 1.45M
Income Statement
Follow revenue through to earnings
Review sales, margins, expenses, and profit trends to see what is actually driving reported earnings over time.
Earnings Waterfall
Revenue to Net Income
Key Ratios
Analysis
$13.0M of revenue converted into -$75.0M of net income for the selected period. Gross margin is -98.9% and net margin is -562.2%, showing how much revenue survives after costs and taxes. EPS is $-1.15, tying the income statement back to per-share earnings.
Income Statement
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $13.0M +15.4% | $11.3M +13.9% | $9.9M +15.5% | $8.6M +557.8% | $1.3M | $809.6M | $921.6M | $731.2M |
| Cost of Revenue | $25.8M +17.9% | $21.9M +32.7% | $16.5M +6.7% | $15.5M +448.9% | $2.8M | $725.6M | $804.0M | $882.4M |
| Gross Profit | -$12.8M -20.5% | -$10.6M -60.9% | -$6.6M +4.2% | -$6.9M -355.0% | -$1.5M | $8.9B | $7.6B | $6.2B |
| Gross Margin | -98.2% -4.2pp | -94.0% -27.5pp | -66.6% +13.7pp | -80.2% +35.7pp | -116.0% | 9.8% | 28.9% | 38.3% |
| Research & Development | $19.2M -4.7% | $20.2M -22.5% | $26.0M -1.7% | $26.5M +54.8% | $17.1M | $983.2M | $1.3B | $490.4M |
| Selling, General & Admin | $27.1M +5.2% | $25.7M -9.3% | $28.4M -37.8% | $45.6M +9.3% | $41.7M | $620.6M | $923.0M | -$1.5B |
| Operating Expenses | $47.9M +3.8% | $46.1M -17.6% | $56.0M -22.6% | $72.3M +20.5% | $60.0M | $5.3B | $7.0B | $8.7B |
| Depreciation & Amortization | $11.7M -0.3% | $11.7M -0.7% | $11.8M +2.6% | $11.5M +402.3% | $2.3M | $374.2M | $1.2B | $631.8M |
| EBITDA | -$49.0M -8.9% | -$45.0M +5.6% | -$47.7M +37.0% | -$75.7M -27.7% | -$59.3M | -$15.2B | $6.8B | $9.3B |
| EBITDA Margin | -376.3% +22.6pp | -398.9% +82.6pp | -481.5% +400.9pp | -882.4% +3662.5pp | -4544.9% | 5.6% | 46.3% | 42.0% |
| Operating Income | -$60.7M -7.0% | -$56.7M +9.3% | -$62.6M +43.0% | -$109.7M -78.2% | -$61.6M | $12.3B | $14.0B | -$15.7B |
| Operating Margin | -466.2% +36.8pp | -502.9% +129.0pp | -631.9% +647.1pp | -1279.0% +3441.7pp | -4720.7% | 16.6% | 24.1% | 22.0% |
| Interest Income | $1.4M -50.4% | $2.9M +73.7% | $1.7M +109.4% | $789.0K | $0 | -$1.5B | -$1.6B | $405.0M |
| Interest Expense | $0 | $0 | $0 | $0 -100.0% | $288.0K | $1.1B | $1.0B | $1.2B |
| Other Income / Expenses | -$16.1M -661.0% | $2.9M +94.8% | $1.5M +110.0% | -$14.7M -4993.4% | -$288.0K | -$1.5B | $1.4B | $1.2B |
| Income Before Tax | -$76.8M -42.6% | -$53.9M +11.8% | -$61.1M +43.9% | -$108.9M -76.1% | -$61.8M | $3.3B | $4.9B | $3.6B |
| Pre-Tax Margin | -589.9% -112.4pp | -477.5% +139.5pp | -617.0% +652.8pp | -1269.8% +3473.0pp | -4742.8% | 20.8% | 18.7% | 26.2% |
| Income Tax Expense | -$1.8M -400.6% | -$358.0K -5.6% | -$339.0K +90.8% | -$3.7M -7562.5% | -$48.0K | $1.3B | -$1.6B | $745.2M |
| Net Income | -$75.0M -40.2% | -$53.5M +11.9% | -$60.8M +42.3% | -$105.2M -70.3% | -$61.8M | $4.9B | $4.8B | $4.7B |
| Net Margin | -576.1% -101.8pp | -474.3% +139.3pp | -613.6% +613.3pp | -1226.9% +3512.2pp | -4739.1% | 12.4% | 17.5% | 22.5% |
| EPS (Basic) | -$1 -27.5% | -$1 +15.7% | -$1 +46.3% | -$2 -57.0% | -$1 | $400.8M | $703.2M | $1.3B |
| EPS (Diluted) | -$1 -27.5% | -$1 +15.7% | -$1 +46.3% | -$2 -57.0% | -$1 | $766.2M | $609.4M | $452.6M |
| Weighted Avg Shares | $64.8M +10.5% | $58.6M +4.0% | $56.4M +7.9% | $52.2M +8.3% | $48.2M | $757.8M | $925.8M | $1.1B |
| Weighted Avg Shares (Diluted) | $64.8M +10.5% | $58.6M +4.0% | $56.4M +7.9% | $52.2M +8.3% | $48.2M | $1.2B | $924.4M | $678.0M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Perspective Therapeutics, Inc.
AMEX:CATX
$227.89M
Profound Medical Corp.
NASDAQ:PROF
$200.47M
Inogen, Inc.
NASDAQ:INGN
$173.28M
Quanterix Corporation
NASDAQ:QTRX
$146.03M
TriSalus Life Sciences, Inc.
NASDAQ:TLSI
$142.92M
Health Catalyst, Inc.
NASDAQ:HCAT
$136.70M
SANUWAVE Health, Inc.
NASDAQ:SNWV
$128.21M
MaxCyte, Inc.
NASDAQ:MXCT
$119.98M
Solana Company
NASDAQ:HSDT
$89.92M
Outset Medical, Inc.
NASDAQ:OM
$83.23M
SEC Filings
Recent regulatory filings
No filings found.
How much revenue does NNOX generate?
Nano-X Imaging Ltd. (NNOX) reported $13.02M of revenue in fiscal 2025.
Is NNOX profitable?
Nano-X Imaging Ltd. (NNOX) reported -$75,018,000.00 of net income, with a net margin of -576.1%.
Explore More
Continue the stock analysis
Jump to another research area for this company.